| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/08/2013 | US8552068 Compositions and methods |
| 10/08/2013 | US8552016 Anti-cancer cyclopenta(g)quinazoline compounds |
| 10/08/2013 | US8551953 Treatment of T-cell mediated diseases |
| 10/03/2013 | US20130261336 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 10/03/2013 | US20130261187 Compounds and methods for delivery of prostacyclin analogs |
| 10/01/2013 | US8546350 Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
| 10/01/2013 | CA2541989C P70s6 kinase modulators and method of use |
| 10/01/2013 | CA2535770C Method for detecting cancer cells and monitoring cancer therapy |
| 09/26/2013 | US20130253199 Polymorphic Forms of Naltrexone |
| 09/26/2013 | US20130253000 Treatment of solid tumors with rapamycin derivatives |
| 09/26/2013 | US20130252940 c-Met Modulators and Method of Use |
| 09/25/2013 | EP2641615A2 Compositions comprising dietary fat complexer and methods for their use |
| 09/24/2013 | US8541472 used to sanitize and treat medical/dental equipment including implants, water storage, distribution and treatment facilities, industrial equipment and food preparation and processing equipment; safe, used to prevent/reduce/eliminate infections |
| 09/24/2013 | US8541429 Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 09/24/2013 | CA2540809C Lpa receptor agonists and antagonists and methods of use |
| 09/24/2013 | CA2522359C Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions |
| 09/24/2013 | CA2490100C Pharmaceutical formulation for use in treating drug withdrawal and preparation method |
| 09/24/2013 | CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 09/19/2013 | US20130244951 Treatment of solid tumors with rapamycin derivatives |
| 09/19/2013 | US20130243786 Treatment of juvenile rheumatoid arthritis (jra) |
| 09/19/2013 | US20130243763 TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIES |
| 09/18/2013 | CN1942176B Pharmaceutical compositions for glucocorticoid replacement therapy |
| 09/18/2013 | CN101413143B Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 09/17/2013 | US8536363 Compounds and methods for delivery of prostacyclin analogs |
| 09/17/2013 | US8536156 Contraception process and administration form for the same |
| 09/17/2013 | US8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/17/2013 | CA2515890C Novel insertion sites in pox vectors |
| 09/10/2013 | US8530655 HIV replication inhibiting pyrimidines |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529906 Compositions for inducing immune responses |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/05/2013 | US20130230596 Abuse-Resistant Oral Dosage Forms And Method Of Use Thereof |
| 09/04/2013 | EP2633856A2 ATP citrate lyase inhibitors for treating cancer |
| 09/04/2013 | CN1856299B 口服药物释出系统 Oral drug release system |
| 09/04/2013 | CN1622995B Receptor nucleic acids and polypeptides |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524665 Use of secretin in treatments of disorders associated with the amygdala |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN101423492B Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8518983 P38 inhibitors and methods of use thereof |
| 08/27/2013 | US8518362 Stabilization and ionic triggering of nitric oxide release |
| 08/27/2013 | CA2526212C Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 08/27/2013 | CA2516163C High viscosity xanthan polymer preparations |
| 08/20/2013 | US8513406 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 08/20/2013 | US8513196 Treatment of T-cell mediated diseases |
| 08/20/2013 | US8512718 Pharmaceutical composition for topical application |
| 08/20/2013 | US8512683 Flexible and stable emulsion base for formulating stable compositions including suncare, cosmetic, and dermatological compositions |
| 08/20/2013 | US8512318 Robotic arms DLUs for performing surgical tasks |
| 08/20/2013 | US8512221 Automated treatment system for sleep |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/15/2013 | US20130210826 Methods for treating pain |
| 08/15/2013 | US20130210722 Methods for using peptide agonists having glp-1 activity |
| 08/15/2013 | US20130209586 Prevention And Treatment Of Cardiac Arrhythmias |
| 08/14/2013 | CN102060843B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/13/2013 | US8507431 Methods for accelerating wound healing by administration of a preadipocyte modulator or an adipocyte modulator |
| 08/13/2013 | US8507212 Process for in vivo treatment of specific biological targets in bodily fluids |
| 08/13/2013 | US8507017 Desensitizing nicotinic acetylcholine receptors using tetrahydroberberine containing plant extract; blocking dopamine release |
| 08/13/2013 | US8507000 Controlled release formulation of erythromycin derivatives |
| 08/13/2013 | US8506994 Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 08/13/2013 | US8506926 [18F]-furanosylpurine derivatives and uses thereof |
| 08/13/2013 | CA2529761C Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 08/13/2013 | CA2504021C Compositions and methods for transdermal oxybutynin therapy |
| 08/08/2013 | DE3943861B4 Verwendung von 2-Hydroxy-4-methoxybenzophenon-5-sulfonsäure oder deren Salze zur Verringerung der Elastizitätsabnahme der Haare bei Beschädigung des Haarkeratins durch atmosphärische Einwirkungen Use of 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid or salts thereof to reduce the elasticity of hair loss in case of damage of the hair keratin by atmospheric conditions |
| 08/07/2013 | EP2623120A2 Compositions comprising dietary fat complexer and methods for their use |
| 08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
| 08/06/2013 | US8501906 Compounds and methods for treating cancer |
| 08/06/2013 | US8501399 Asymmetrically branched polymer conjugates and microarray assays |
| 08/06/2013 | US8501231 Pharmaceutical compositions providing enhanced drug concentrations |
| 08/06/2013 | CA2732620C Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof |
| 08/06/2013 | CA2529949C Antiviral compounds and methods |
| 08/01/2013 | US20130196950 Retinoid replacements and opsin agonists and methods for the use thereof |
| 08/01/2013 | US20130196342 Compositions And Methods For Modulating S-Nitrosogluthione Reductase |
| 08/01/2013 | US20130195890 Treatment of ms with goat serum |
| 07/31/2013 | CN101402562B Novel benzophenone derivatives or salts thereof |
| 07/30/2013 | USRE44400 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
| 07/30/2013 | US8497284 C-met modulators and method of use |
| 07/30/2013 | CA2462886C Flashmelt oral dosage formulation |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 07/25/2013 | US20130189196 Foamable Composition |
| 07/24/2013 | EP2617709A1 Guanidine derivatives as antiviral agents |
| 07/24/2013 | EP2617419A1 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 07/24/2013 | EP2617411A1 Methods for the Treatment of Endometriosis |
| 07/24/2013 | CN1904204B Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom |
| 07/24/2013 | CN1705740B Adenovirus expressing genes in reverse order and use thereof |
| 07/24/2013 | CN101669900B Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/23/2013 | CA2377357C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/18/2013 | US20130184242 Pharmaceutical Composition for Topical Application |
| 07/18/2013 | US20130183333 Induced activation in dendritic cells |
| 07/18/2013 | US20130183271 Methods and Compositions Concerning Poxviruses and Cancer |
| 07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
| 07/16/2013 | US8486910 SnoRNAi-small nucleolar RNA degradation by RNA interference in trypanosomatids |
| 07/16/2013 | US8486457 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 07/16/2013 | US8486455 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/16/2013 | CA2741575C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/16/2013 | CA2741412C Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/16/2013 | CA2549115C Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/16/2013 | CA2540159C Extended release venlafaxine formulation |